Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Suñé C[au]:

Identification of TCERG1 as a new genetic modulator of TDP-43 production in Drosophila. Pons M et al. Acta Neuropathol Commun. (2018)

Targeting Splicing in the Treatment of Human Disease. Suñé-Pou M et al. Genes (Basel). (2017)

Targeting proteins to RNA transcription and processing sites within the nucleus. Sánchez-Hernández N et al. Int J Biochem Cell Biol. (2017)

Search results

Items: 1 to 50 of 53

1.

Role for the splicing factor TCERG1 in Cajal body integrity and snRNP assembly.

Moreno-Castro C, Prieto-Sánchez S, Sánchez-Hernández N, Hernández-Munain C, Suñé C.

J Cell Sci. 2019 Nov 14;132(22). pii: jcs232728. doi: 10.1242/jcs.232728.

PMID:
31636114
2.

Development and characterization of an improved formulation of cholesteryl oleate-loaded cationic solid-lipid nanoparticles as an efficient non-viral gene delivery system.

Limeres MJ, Suñé-Pou M, Prieto-Sánchez S, Moreno-Castro C, Nusblat AD, Hernández-Munain C, Castro GR, Suñé C, Suñé-Negre JM, Cuestas ML.

Colloids Surf B Biointerfaces. 2019 Dec 1;184:110533. doi: 10.1016/j.colsurfb.2019.110533. Epub 2019 Sep 29.

PMID:
31593829
3.

Improved synthesis and characterization of cholesteryl oleate-loaded cationic solid lipid nanoparticles with high transfection efficiency for gene therapy applications.

Suñé-Pou M, Limeres MJ, Nofrerias I, Nardi-Ricart A, Prieto-Sánchez S, El-Yousfi Y, Pérez-Lozano P, García-Montoya E, Miñarro-Carmona M, Ticó JR, Hernández-Munain C, Suñé C, Suñé-Negre JM.

Colloids Surf B Biointerfaces. 2019 Aug 1;180:159-167. doi: 10.1016/j.colsurfb.2019.04.037. Epub 2019 Apr 17.

PMID:
31048241
4.

Identification of TCERG1 as a new genetic modulator of TDP-43 production in Drosophila.

Pons M, Prieto S, Miguel L, Frebourg T, Campion D, Suñé C, Lecourtois M.

Acta Neuropathol Commun. 2018 Dec 12;6(1):138. doi: 10.1186/s40478-018-0639-5.

5.

Cholesteryl oleate-loaded cationic solid lipid nanoparticles as carriers for efficient gene-silencing therapy.

Suñé-Pou M, Prieto-Sánchez S, El Yousfi Y, Boyero-Corral S, Nardi-Ricart A, Nofrerias-Roig I, Pérez-Lozano P, García-Montoya E, Miñarro-Carmona M, Ticó JR, Suñé-Negre JM, Hernández-Munain C, Suñé C.

Int J Nanomedicine. 2018 May 30;13:3223-3233. doi: 10.2147/IJN.S158884. eCollection 2018.

6.

Targeting proteins to RNA transcription and processing sites within the nucleus.

Sánchez-Hernández N, Prieto-Sánchez S, Moreno-Castro C, Muñoz-Cobo JP, El Yousfi Y, Boyero-Corral S, Suñé-Pou M, Hernández-Munain C, Suñé C.

Int J Biochem Cell Biol. 2017 Oct;91(Pt B):194-202. doi: 10.1016/j.biocel.2017.06.001. Epub 2017 Jun 6. Review.

PMID:
28600144
7.

Targeting Splicing in the Treatment of Human Disease.

Suñé-Pou M, Prieto-Sánchez S, Boyero-Corral S, Moreno-Castro C, El Yousfi Y, Suñé-Negre JM, Hernández-Munain C, Suñé C.

Genes (Basel). 2017 Feb 24;8(3). pii: E87. doi: 10.3390/genes8030087. Review.

8.

Transcriptional Elongation Regulator 1 Affects Transcription and Splicing of Genes Associated with Cellular Morphology and Cytoskeleton Dynamics and Is Required for Neurite Outgrowth in Neuroblastoma Cells and Primary Neuronal Cultures.

Muñoz-Cobo JP, Sánchez-Hernández N, Gutiérrez S, El Yousfi Y, Montes M, Gallego C, Hernández-Munain C, Suñé C.

Mol Neurobiol. 2017 Dec;54(10):7808-7823. doi: 10.1007/s12035-016-0284-6. Epub 2016 Nov 14.

PMID:
27844289
9.

Improved formulation of cationic solid lipid nanoparticles displays cellular uptake and biological activity of nucleic acids.

Fàbregas A, Prieto-Sánchez S, Suñé-Pou M, Boyero-Corral S, Ticó JR, García-Montoya E, Pérez-Lozano P, Miñarro M, Suñé-Negre JM, Hernández-Munain C, Suñé C.

Int J Pharm. 2017 Jan 10;516(1-2):39-44. doi: 10.1016/j.ijpharm.2016.11.026. Epub 2016 Nov 10.

PMID:
27840160
10.

The in vivo dynamics of TCERG1, a factor that couples transcriptional elongation with splicing.

Sánchez-Hernández N, Boireau S, Schmidt U, Muñoz-Cobo JP, Hernández-Munain C, Bertrand E, Suñé C.

RNA. 2016 Apr;22(4):571-82. doi: 10.1261/rna.052795.115. Epub 2016 Feb 12.

11.

Prp40 and early events in splice site definition.

Becerra S, Andrés-León E, Prieto-Sánchez S, Hernández-Munain C, Suñé C.

Wiley Interdiscip Rev RNA. 2016 Jan-Feb;7(1):17-32. doi: 10.1002/wrna.1312. Epub 2015 Oct 23. Review.

PMID:
26494226
12.

Functional Consequences for Apoptosis by Transcription Elongation Regulator 1 (TCERG1)-Mediated Bcl-x and Fas/CD95 Alternative Splicing.

Montes M, Coiras M, Becerra S, Moreno-Castro C, Mateos E, Majuelos J, Oliver FJ, Hernández-Munain C, Alcamí J, Suñé C.

PLoS One. 2015 Oct 13;10(10):e0139812. doi: 10.1371/journal.pone.0139812. eCollection 2015.

13.

Prp40 pre-mRNA processing factor 40 homolog B (PRPF40B) associates with SF1 and U2AF65 and modulates alternative pre-mRNA splicing in vivo.

Becerra S, Montes M, Hernández-Munain C, Suñé C.

RNA. 2015 Mar;21(3):438-57. doi: 10.1261/rna.047258.114. Epub 2015 Jan 20.

14.

A new optimized formulation of cationic solid lipid nanoparticles intended for gene delivery: development, characterization and DNA binding efficiency of TCERG1 expression plasmid.

Fàbregas A, Sánchez-Hernández N, Ticó JR, García-Montoya E, Pérez-Lozano P, Suñé-Negre JM, Hernández-Munain C, Suñé C, Miñarro M.

Int J Pharm. 2014 Oct 1;473(1-2):270-9. doi: 10.1016/j.ijpharm.2014.06.022. Epub 2014 Jul 3.

PMID:
24999055
15.

Transcription elongation regulator 1 (TCERG1) regulates competent RNA polymerase II-mediated elongation of HIV-1 transcription and facilitates efficient viral replication.

Coiras M, Montes M, Montanuy I, López-Huertas MR, Mateos E, Le Sommer C, Garcia-Blanco MA, Hernández-Munain C, Alcamí J, Suñé C.

Retrovirology. 2013 Oct 28;10:124. doi: 10.1186/1742-4690-10-124.

16.

DNA delivery via cationic solid lipid nanoparticles (SLNs).

Carrillo C, Sánchez-Hernández N, García-Montoya E, Pérez-Lozano P, Suñé-Negre JM, Ticó JR, Suñé C, Miñarro M.

Eur J Pharm Sci. 2013 May 13;49(2):157-65. doi: 10.1016/j.ejps.2013.02.011. Epub 2013 Feb 27.

PMID:
23454134
17.

Indications of microsurgery in soft tissue sarcomas.

Viñals JM, Rodrigues TA, Sildenikova DP, Payro JM, Porté JA, Suñe CH, Ojeda AL, Vidal JM, Dewever M, Lopez CC, Segu JO, Chavarria FA.

J Reconstr Microsurg. 2012 Nov;28(9):619-25. doi: 10.1055/s-0032-1326740. Epub 2012 Sep 21.

PMID:
23023807
18.

Gene Control during Transcription Elongation.

Chávez S, Gross DS, Hermand D, Suñé C.

Genet Res Int. 2012;2012:758384. doi: 10.1155/2012/758384. Epub 2012 Mar 25. No abstract available.

19.

Functional coupling of transcription and splicing.

Montes M, Becerra S, Sánchez-Álvarez M, Suñé C.

Gene. 2012 Jun 15;501(2):104-17. doi: 10.1016/j.gene.2012.04.006. Epub 2012 Apr 17. Review.

20.

The FF4 and FF5 domains of transcription elongation regulator 1 (TCERG1) target proteins to the periphery of speckles.

Sánchez-Hernández N, Ruiz L, Sánchez-Álvarez M, Montes M, Macias MJ, Hernández-Munain C, Suñé C.

J Biol Chem. 2012 May 18;287(21):17789-800. doi: 10.1074/jbc.M111.304782. Epub 2012 Mar 27.

21.

TCERG1 regulates alternative splicing of the Bcl-x gene by modulating the rate of RNA polymerase II transcription.

Montes M, Cloutier A, Sánchez-Hernández N, Michelle L, Lemieux B, Blanchette M, Hernández-Munain C, Chabot B, Suñé C.

Mol Cell Biol. 2012 Feb;32(4):751-62. doi: 10.1128/MCB.06255-11. Epub 2011 Dec 12.

22.

Spatial Organization and Dynamics of Transcription Elongation and Pre-mRNA Processing in Live Cells.

Sánchez-Álvarez M, Sánchez-Hernández N, Suñé C.

Genet Res Int. 2011;2011:626081. doi: 10.4061/2011/626081. Epub 2011 Nov 24.

23.

Transcription elongation regulator 1 is a co-integrator of the cell fate determination factor Dachshund homolog 1.

Zhou J, Liu Y, Zhang W, Popov VM, Wang M, Pattabiraman N, Suñé C, Cvekl A, Wu K, Jiang J, Wang C, Pestell RG.

J Biol Chem. 2010 Dec 17;285(51):40342-50. doi: 10.1074/jbc.M110.156141. Epub 2010 Oct 18.

24.

Differential effects of sumoylation on transcription and alternative splicing by transcription elongation regulator 1 (TCERG1).

Sánchez-Alvarez M, Montes M, Sánchez-Hernández N, Hernández-Munain C, Suñé C.

J Biol Chem. 2010 May 14;285(20):15220-33. doi: 10.1074/jbc.M109.063750. Epub 2010 Mar 9.

25.

Promoter influences transcription elongation: TATA-box element mediates the assembly of processive transcription complexes responsive to cyclin-dependent kinase 9.

Montanuy I, Torremocha R, Hernández-Munain C, Suñé C.

J Biol Chem. 2008 Mar 21;283(12):7368-78. doi: 10.1074/jbc.M706243200. Epub 2008 Jan 24.

27.

Natural polymorphisms in the protease gene modulate the replicative capacity of non-B HIV-1 variants in the absence of drug pressure.

Holguín A, Suñe C, Hamy F, Soriano V, Klimkait T.

J Clin Virol. 2006 Aug;36(4):264-71. Epub 2006 Jun 12.

PMID:
16765636
28.

Effect of polymorphisms on the replicative capacity of protease inhibitor-resistant HIV-1 variants under drug pressure.

Suñé C, Brennan L, Stover DR, Klimkait T.

Clin Microbiol Infect. 2004 Feb;10(2):119-26.

29.

A neutravidin-based assay for reverse transcriptase suitable for high throughput screening of retroviral activity.

Brennan LE, Suñé C, Klimkait T.

J Biochem Mol Biol. 2002 May 31;35(3):262-6.

PMID:
12297021
30.

The transcription elongation factor CA150 interacts with RNA polymerase II and the pre-mRNA splicing factor SF1.

Goldstrohm AC, Albrecht TR, Suñé C, Bedford MT, Garcia-Blanco MA.

Mol Cell Biol. 2001 Nov;21(22):7617-28.

31.

Expression analysis and mapping of the mouse and human transcriptional regulator CA150.

Bohne J, Cole SE, Suñe C, Lindman BR, Ko VD, Vogt TF, Garcia-Blanco MA.

Mamm Genome. 2000 Oct;11(10):930-3. No abstract available.

PMID:
11003711
33.

Protein-interaction modules that organize nuclear function: FF domains of CA150 bind the phosphoCTD of RNA polymerase II.

Carty SM, Goldstrohm AC, Suñé C, Garcia-Blanco MA, Greenleaf AL.

Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9015-20.

34.
35.
36.
37.

Induction of antibodies protecting against transmissible gastroenteritis coronavirus (TGEV) by recombinant adenovirus expressing TGEV spike protein.

Torres JM, Sánchez C, Suñé C, Smerdou C, Prevec L, Graham F, Enjuanes L.

Virology. 1995 Nov 10;213(2):503-16.

40.

Membrane protein molecules of transmissible gastroenteritis coronavirus also expose the carboxy-terminal region on the external surface of the virion.

Risco C, Antón IM, Suñé C, Pedregosa AM, Martín-Alonso JM, Parra F, Carrascosa JL, Enjuanes L.

J Virol. 1995 Sep;69(9):5269-77.

42.

Induction of transmissible gastroenteritis coronavirus specific immune responses using vectors with enteric tropism.

Enjuanes L, Smerdou C, Sanchez CM, Suñé C, Kelly S, Curtiss R 3rd, Torres JM.

Adv Exp Med Biol. 1995;371B:1535-41. No abstract available.

PMID:
7502852
43.

Induction of an immune response to transmissible gastroenteritis coronavirus using vectors with enteric tropism.

Smerdou C, Torres JM, Sánchez CM, Suñé C, Antón IM, Medina M, Castilla J, Graham FL, Enjuanes L.

Adv Exp Med Biol. 1993;342:455-62. No abstract available.

PMID:
7516110
44.

Antigen selection and presentation to protect against transmissible gastroenteritis coronavirus.

Enjuanes L, Suñé C, Gebauer F, Smerdou C, Camacho A, Antón IM, González S, Talamillo A, Méndez A, Ballesteros ML, et al.

Vet Microbiol. 1992 Nov;33(1-4):249-62.

PMID:
1282756
45.

Genetic evolution and tropism of transmissible gastroenteritis coronaviruses.

Sánchez CM, Gebauer F, Suñé C, Mendez A, Dopazo J, Enjuanes L.

Virology. 1992 Sep;190(1):92-105.

PMID:
1326823
46.

A conserved coronavirus epitope, critical in virus neutralization, mimicked by internal-image monoclonal anti-idiotypic antibodies.

Suñé C, Smerdou C, Antón IM, Abril P, Plana J, Enjuanes L.

J Virol. 1991 Dec;65(12):6979-84.

47.

Residues involved in the antigenic sites of transmissible gastroenteritis coronavirus S glycoprotein.

Gebauer F, Posthumus WP, Correa I, Suñé C, Smerdou C, Sánchez CM, Lenstra JA, Meloen RH, Enjuanes L.

Virology. 1991 Jul;183(1):225-38.

PMID:
1711257
48.

Mechanisms of transmissible gastroenteritis coronavirus neutralization.

Suñé C, Jiménez G, Correa I, Bullido MJ, Gebauer F, Smerdou C, Enjuanes L.

Virology. 1990 Aug;177(2):559-69.

PMID:
2164725
49.

Localization of antigenic sites of the E2 glycoprotein of transmissible gastroenteritis coronavirus.

Correa I, Gebauer F, Bullido MJ, Suñé C, Baay MF, Zwaagstra KA, Posthumus WP, Lenstra JA, Enjuanes L.

J Gen Virol. 1990 Feb;71 ( Pt 2):271-9.

PMID:
2155284
50.

Antigenic homology among coronaviruses related to transmissible gastroenteritis virus.

Sánchez CM, Jiménez G, Laviada MD, Correa I, Suñé C, Bullido Mj, Gebauer F, Smerdou C, Callebaut P, Escribano JM, et al.

Virology. 1990 Feb;174(2):410-7.

PMID:
1689525

Supplemental Content

Support Center